Berlin-based global health company Ada has signed more than 10 new partnerships with key players across sciences, insurance and health systems, including AXA OneHealth, Santéclair, Novartis, CUF, TAJ Digital Health and Sutter Health.
These organisations have opted for this partnership in order to improve patient experiences, leveraging Ada’s enterprise solutions to support the delivery of healthcare goals.
WHY IT MATTERS
The last year has seen a rapid growth of AI-powered platforms in healthcare, as organisations have looked for solutions to healthcare challenges – including the COVID-19 pandemic, as well as the pressures of growing and ageing populations and rising health inequality globally.
With Ada’s enterprise solutions, partners have access to Ada’s AI-based symptom assessment and care navigation, which helps users to understand their symptoms, identify likely conditions and navigate to appropriate care.
Partners can help users navigate the right care at the right time, while freeing up time and resources for their team. Ada also offers optional embedded appointment booking, single sign-on features, integration into the partner’s electronic patient record and advanced data insights, giving every partner the ability to tailor the integration to their organisation’s specific needs.
THE LARGER CONTEXT
Ada has been busy expanding its suite of solutions in the last few months. In May, it secured a $90 million Series B funding to advance its health assessment technology.
The AI health assessment company also recently partnered with Novartis to use its care navigation solution to help improve the identification and diagnosis of a number of diseases.
ON THE RECORD
Daniel Nathrath, CEO & co-founder of Ada said: “We founded Ada ten years ago because we believed that AI would fundamentally transform healthcare. Today, we are seeing that vision become a reality as organisations across all areas of healthcare turn to AI-powered solutions to help them tackle the unprecedented challenges facing society; from the unique circumstances of COVID-19 to the long-term pressures created by growing and ageing populations.
“We are proud to have signed more than 10 new partners globally in the last 8 months, with more in advanced negotiations, and we look forward to working closely with innovators across life sciences, insurance, health systems and global development as we continue our mission to transform the future of healthcare, and improve health experiences and outcomes for everyone.”
Marianne Binst, CEO of Santéclair, said: “One of our primary reasons for choosing to partner with Ada was the ability to integrate its solution into Santéclair’s unique model. Combined, these two solutions enable us to offer our customers a truly unique service, one unlike anything else on the market in the region, enabling as many as 10 million users across France to benefit from a service that has been tested by Santéclair’s Health Innovation Lab.
“The medical quality, algorithm efficiency and user experience of the Ada platform were all key factors when it came to selecting the right solution. With Ada, we saw the same commitment to high standards that we guarantee to our customers; this is a core shared value, and one which will help enable us to further our strategic ambition as an innovative company with the Mysantéclair digital platform.”